239 related articles for article (PubMed ID: 21699479)
21. Poorly differentiated chordoma with whole-genome doubling evolving from a SMARCB1-deficient conventional chordoma: A case report.
Curcio C; Cimera R; Aryeequaye R; Rao M; Fabbri N; Zhang Y; Hameed M
Genes Chromosomes Cancer; 2021 Jan; 60(1):43-48. PubMed ID: 32920865
[TBL] [Abstract][Full Text] [Related]
22. Parosteal extra-axial chordoma of the second metacarpal bone: a case report with literature review.
Tsukamoto S; Vanel D; Righi A; Donati DM; Errani C
Skeletal Radiol; 2018 Apr; 47(4):579-585. PubMed ID: 29151144
[TBL] [Abstract][Full Text] [Related]
23. Randomized, Double-Blind, Placebo-Controlled Phase II Study of Yeast-Brachyury Vaccine (GI-6301) in Combination with Standard-of-Care Radiotherapy in Locally Advanced, Unresectable Chordoma.
DeMaria PJ; Bilusic M; Park DM; Heery CR; Donahue RN; Madan RA; Bagheri MH; Strauss J; Shen V; Marté JL; Steinberg SM; Schlom J; Gilbert MR; Gulley JL
Oncologist; 2021 May; 26(5):e847-e858. PubMed ID: 33594772
[TBL] [Abstract][Full Text] [Related]
24. Transcriptional Profiling Supports the Notochordal Origin of Chordoma and Its Dependence on a TGFB1-TBXT Network.
Halvorsen SC; Benita Y; Hopton M; Hoppe B; Gunnlaugsson HO; Korgaonkar P; Vanderburg CR; Nielsen GP; Trepanowski N; Cheah JH; Frosch MP; Schwab JH; Rosenberg AE; Hornicek FJ; Sassi S
Am J Pathol; 2023 May; 193(5):532-547. PubMed ID: 36804377
[TBL] [Abstract][Full Text] [Related]
25. Clinical findings in families with chordoma with and without T gene duplications and in patients with sporadic chordoma reported to the Surveillance, Epidemiology, and End Results program.
Parry DM; McMaster ML; Liebsch NJ; Patronas NJ; Quezado MM; Zametkin D; Yang XR; Goldstein AM
J Neurosurg; 2020 Jun; 134(5):1399-1408. PubMed ID: 32559743
[TBL] [Abstract][Full Text] [Related]
26. Recurrent loss of chromosome 22 and SMARCB1 deletion in extra-axial chordoma: A clinicopathological and molecular analysis.
Wen X; Cimera R; Aryeequaye R; Abhinta M; Athanasian E; Healey J; Fabbri N; Boland P; Zhang Y; Hameed M
Genes Chromosomes Cancer; 2021 Dec; 60(12):796-807. PubMed ID: 34392582
[TBL] [Abstract][Full Text] [Related]
27. The transcriptional factors CDX2 and FOXA1 in chordomas.
Dridi M; Boutonnat J; Dumollard JM; Peoc'h M; Karpathiou G
Pathol Res Pract; 2020 Nov; 216(11):153160. PubMed ID: 32911347
[TBL] [Abstract][Full Text] [Related]
28. Chordoma cells possess bone-dissolving activity at the bone invasion front.
Kawaai K; Oishi Y; Kuroda Y; Tamura R; Toda M; Matsuo K
Cell Oncol (Dordr); 2024 Apr; ():. PubMed ID: 38652222
[TBL] [Abstract][Full Text] [Related]
29. The T-box transcription factor brachyury behaves as a tumor suppressor in gliomas.
Pinto F; Costa ÂM; Santos GC; Matsushita MM; Costa S; Silva VA; Miranda-Gonçalves V; Lopes CM; Clara CA; Becker AP; Neder L; Hajj GN; da Cunha IW; Jones C; Andrade RP; Reis RM
J Pathol; 2020 May; 251(1):87-99. PubMed ID: 32154590
[TBL] [Abstract][Full Text] [Related]
30. Transactivation of SOX5 by Brachyury promotes breast cancer bone metastasis.
Chen M; Zou S; He C; Zhou J; Li S; Shen M; Cheng R; Wang D; Zou T; Yan X; Huang Y; Shen J
Carcinogenesis; 2020 Jul; 41(5):551-560. PubMed ID: 31713604
[TBL] [Abstract][Full Text] [Related]
31. Emerging Therapeutic Targets in Chordomas: A Review of the Literature in the Genomic Era.
Gill CM; Fowkes M; Shrivastava RK
Neurosurgery; 2020 Feb; 86(2):E118-E123. PubMed ID: 31504814
[TBL] [Abstract][Full Text] [Related]
32. Snail Transcriptionally Represses
Wu B; Ouyang X; Yang X; Dong B
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542387
[TBL] [Abstract][Full Text] [Related]
33. Transfection of T-Box Transcription Factor
Akimoto N; Nakamura K; Hijioka H; Kume K; Matsumura Y; Sugiura T
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30453543
[TBL] [Abstract][Full Text] [Related]
34. Impact of CDK Inhibitors on
Bette S; Haase L; Nell J; Grieser T; von Baer A; Schultheiss M; Marienfeld R; Möller P; Barth TFE; Mellert K
Diagnostics (Basel); 2024 May; 14(10):. PubMed ID: 38786326
[TBL] [Abstract][Full Text] [Related]
35. Characterization of a Clival Chordoma Xenograft Model Reveals Tumor Genomic Instability.
Diaz RJ; Luck A; Bondoc A; Golbourn B; Picard D; Remke M; Loukides J; Sabha N; Smith C; Cusimano MD; Rutka JT
Am J Pathol; 2018 Dec; 188(12):2902-2911. PubMed ID: 30248342
[TBL] [Abstract][Full Text] [Related]
36. Development of a Novel Orthotopic Primary Human Chordoma Xenograft Model: A Relevant Support for Future Research on Chordoma.
Salle H; Pocard M; Lehmann-Che J; Bourthoumieu S; Labrousse F; Pimpie C; Lemnos L; Guichard JP; Froelich S; Adle-Biassette H
J Neuropathol Exp Neurol; 2020 Mar; 79(3):314-324. PubMed ID: 31841164
[TBL] [Abstract][Full Text] [Related]
37. Unraveling molecular advancements in chordoma tumorigenesis and treatment response: a review of scientific discoveries and clinical implications.
Jin MC; Connolly ID; Ravi K; Tobert DG; MacDonald SM; Shin JH
Neurosurg Focus; 2024 May; 56(5):E18. PubMed ID: 38691860
[TBL] [Abstract][Full Text] [Related]
38. Conserved enhancers control notochord expression of vertebrate Brachyury.
Kemmler CL; Smolikova J; Moran HR; Mannion BJ; Knapp D; Lim F; Czarkwiani A; Hermosilla Aguayo V; Rapp V; Fitch OE; Bötschi S; Selleri L; Farley E; Braasch I; Yun M; Visel A; Osterwalder M; Mosimann C; Kozmik Z; Burger A
Nat Commun; 2023 Oct; 14(1):6594. PubMed ID: 37852970
[TBL] [Abstract][Full Text] [Related]
39. U-CH17P, -M and -S, a new cell culture system for tumor diversity and progression in chordoma.
Jäger D; Lechel A; Tharehalli U; Seeling C; Möller P; Barth TFE; Mellert K
Int J Cancer; 2018 Apr; 142(7):1369-1378. PubMed ID: 29148152
[TBL] [Abstract][Full Text] [Related]
40. Inhibition Of Glycogen Synthase Kinase 3 Beta Suppresses The Growth And Survival Of Skull Base Chordoma Cells By Downregulating Brachyury Expression.
Yan X; Li Z; Li H; Liu P; Zhao Z; Cheng S; Wang Z; Zhang Q
Onco Targets Ther; 2019; 12():9783-9791. PubMed ID: 31819479
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
